SlideShare a Scribd company logo
DIABETIC KETOACIDOSIS

ISPAD Clinical Practice Consensus Guidelines
            2009 Compendium
    Diabetic ketoacidosis in children and
          adolescents with diabetes
Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J,
 Lee W, Rosenbloom A, Sperling M, and Hanas R.

Pediatric Diabetes 2009: 10 (Suppl. 12): 118–133.
DIABETIC KETOACIDOSIS
   BSPED Recommended DKA Guidelines 2009
WORKING GROUP OF THE BRITISH SOCIETY OF
PAEDIATRIC ENDOCRINOLOGY AND DIABETES
Dr. Julie Edge, Consultant in Paediatric Diabetes,
Oxford Children’s Hospital,

      • 1. Recommendation to use capillary blood
        ketone measurement during treatment
      • 2. Reduction in the degree of dehydration to be
        used to calculate fluids
      • 3. Reduction in maintenance fluid rates
DIABETIC KETOACIDOSIS
  BSPED Recommended DKA Guidelines 2009

• 4. Change in the recommendations for PICU/HDU –
  more emphasis on safe nursing on general wards
• 5. Continuation of Normal saline for the first 12
  hours of rehydration
• 6. Delay in insulin until fluids have been running for
  an hour
• 7. Option to continue insulin glargine during
  treatment
DIABETIC KETOACIDOSIS
  BSPED Recommended DKA Guidelines 2009
• 8. Reminder to stop insulin pump therapy during
  treatment
• 9. Reminder to consider anticoagulant prophylaxis
  in young children, especially those with femoral
  lines
• 10. Interpretation of blood ketone measurements if
  pH not improving
• 11. Option to use hypertonic saline instead of
  mannitol for the treatment of cerebral oedema
DIABETIC KETOACIDOSIS
  BSPED Recommended DKA Guidelines 2009

CAUTION
 These guidelines are believed to be as safe
 as possible in the light of current evidence.
 However, no guidelines can be considered
 entirely safe as complications may still
 arise. In particular the pathophysiology of
 cerebral oedema is still poorly understood.
A. GENERAL :

• Always consult with a more senior doctor on
  call as soon as you suspect DKA even if you
  feel confident of your management.
Remember : children can die from DKA.
         They can die from –
• Cerebral oedema
• Hypokalaemia
• Aspiration pneumonia
Definition:
• children and young people who have:
• hyperglycaemia (BG >11 mmol/l)
• pH < 7.3
• bicarbonate < 15 mmol/l      and who are
                   more than 3% dehydrated
                   and/or vomiting
                   and/or drowsy
                   and/or clinically acidotic
•   Children who are 5% dehydrated or less and not clinically unwell (mild acidosis and not
    nauseated or vomiting) usually tolerate oral rehydration and subcutaneous insulin.
B. EMERGENCY
    MANAGEMENT IN A & E :
• 1. General Resuscitation : A, B, C.
  Only if shocked (poor peripheral pulses, poor capillary filling with
  tachycardia, and/or hypotension) give 10 ml/kg 0.9% saline as a
  bolus, and repeat as necessary to a maximum of 30 ml/kg.
• 2. Confirm the Diagnosis :
• 3. Initial Investigations :
blood glucose urea and electrolytesblood gases near
 patient blood ketones + other investigations only if
 indicated e.g. PCV and full blood count, CXR, CSF, throat
 swab, blood culture, urinalysis, c and s etc. (DKA may
 rarely be ppted by sepsis, and fever is not part of DKA.)
C. FULL CLINICAL ASSESSMENT
    AND OBSERVATIONS :
• 1. Degree of Dehydration –


  Over-estimation of degree of dehydration is dangerous.
Therefore do not use more than 8% dehydration in calculations
• 2. Conscious Level –
 Institute hourly neurological observations including G C S whether or not drowsy on admission.

• 3. Full Examination - looking particularly for evidence of
  - cerebral oedema infection ileus
 WEIGH THE CHILD. If this is not possible because of the clinical condition, use the
  most recent clinic weight as a guideline, or an estimated weight from centile charts.
C. FULL CLINICAL ASSESSMENT
     AND OBSERVATIONS :

4.   Consider PICU or HDU for the following, and
     discuss with a PICU consultant.
• severe acidosis pH<7.1 with marked hyperventilation
• severe dehydration with shock
• depressed sensorium with risk of aspiration from
  vomiting
• very young (under 2 years)
• staffing levels on the wards are insufficient to allow
  adequate monitoring
C. FULL CLINICAL ASSESSMENT
    AND OBSERVATIONS :
5. Observations to be carried out : recording all results and clinical
   signs on a flow chart.
• strict fluid balance
• measurement of volume of every urine sample
• hourly capillary blood glucose measurements
• capillary blood ketone levels every 1-2 hours (if available)
• urine testing for ketones (if blood ketone testing not available)
• hourly BP and basic observations
• twice daily weight; can be helpful in assessing fluid balance
• hourly or more frequent neurological observations initially
• reporting immediately to the medical staff, even at night, symptoms of
  headache, or slowing of pulse rate, or any change in either conscious level or
  behaviour
• reporting any changes in the ECG trace, especially T wave changes suggesting
  hyper- or hypokalaemia
D. MANAGEMENT :
1. FLUIDS :
• a) Volume of fluid –
  Requirement = Maintenance + Deficit – fluid already given
  For most children, use 5% to 8% dehydration to calculate fluids.
  Maintenance requirements:
  Weight         0 – 12.9 kg    80 ml/kg/24 hrs
                 13 – 19.9 kg 65 ml/kg/24 hrs
                 20 – 34.9 kg 55 ml/kg/24 hrs
                 35 – 59.9 kg 45 ml/kg/24 hrs
                 adult (>60 kg) 35 ml/kg/24 hrs



   N.B. Neonatal DKA will require special consideration and larger volumes of fluid
   than those quoted may be required, usually 100-150 ml/kg/24 hours)
D. MANAGEMENT :DKACalculator
D. MANAGEMENT :
  1. FLUIDS :
     b) Type of fluid -
• Initially use 0.9% saline with 20 mmol KCl in 500 ml, and continue
  this sodium concentration for at least 12 hours.
• Once the blood glucose has fallen to 14 mmol/l add glucose to the
  fluid. After 12 hours, if the plasma sodium level is stable or
  increasing, change to 500ml bags of 0.45% saline/5% glucose/20
  mmol KCl.
• If the plasma sodium is falling, continue with Normal saline (with or
  without glucose depending on blood glucose levels).
• Corrected sodium levels should rise as blood glucose levels fall
  during treatment. If they do not, then continue with Normal saline and
  do not change to 0.45% saline.
D. MANAGEMENT :
1. FLUIDS :
   c) Oral Fluids :

   • In severe dehydration, impaired consciousness &
     acidosis do not allow fluids by mouth. A N/G tube may be
     necessary in the case of gastric paresis.

   • Oral fluids (eg fruit juice/oral rehydration solution)
     should only be offered after substantial clinical
     improvement and no vomiting
   • When good clinical improvement occurs before the 48hr
     rehydration period is completed, oral intake may proceed
     and the need for IV infusions reduced to take account of
     the oral intake.
D. MANAGEMENT :
 2. POTASSIUM :

• Once the child has been resuscitated, potassium should be
  commenced immediately with rehydration fluid unless
  anuria is suspected. Therefore ensure that every 500 ml bag
  of fluid contains 20 mmol KCl (40 mmol per litre).
• Check U & E's 2 hours after resuscitation is begun and then
  at least 4 hourly, and alter potassium replacements
  accordingly. More potassium than 40 mmol/l is occasionally
  required.
• Use a cardiac monitor and observe frequently for T wave
  changes.
D. MANAGEMENT :
  3. INSULIN :
DO NOT start insulin until intravenous fluids have been running for
at least an hour.
• Continuous low-dose intravenous infusion is the preferred
   method. 0.1 units/kg/hour Do not add insulin directly to the fluid bags.
• Once the blood glucose level falls to 14mmol/l, change the fluid to
   contain 5% glucose (generally 0.9% saline with glucose and
   potassium). DO NOT reduce the insulin.
• DO NOT stop the insulin infusion while glucose is being infused,
   as insulin is required to switch off ketone production. If the blood
   glucose falls below 4 mmol/l, give a bolus of 2 ml/kg of 10%
   glucose and increase the glucose concentration of the infusion.
   Insulin can temporarily be reduced for 1 hour.
D. MANAGEMENT :
• 4. BICARBONATE :
• Bicarbonate should only be considered in children who are profoundly acidotic
  (pH< 6.9) and shocked with circulatory failure. Its only purpose is to improve
  cardiac contractility in severe shock.
• Before starting bicarbonate, discuss with senior staff, and the quantity should be
  decided by the paediatric resuscitation team or consultant on-call.
• 5. PHOSPHATE :
• There is always depletion of phosphate. There is no evidence in adults or children
  that replacement has any clinical benefit and phosphate administration may lead to
  hypocalcaemia.
• 6. ANTICOAGULANT PROPHYLAXIS :
• There is a significant risk of femoral vein thrombosis in young and very sick
  children with DKA who have femoral lines inserted. Therefore consideration should
  be given to anticoagulating these children with 100 units/kg/day as a single daily
  dose of Fragmin.
• Children who are significantly hyperosmolar might also require anticoagulant
  prophylaxis
E. CONTINUING MANAGEMENT
Urinary catheterisation should be avoided but may be useful in the child
  with impaired consciousness.
Documentation of fluid balance is of paramount importance.
If a massive diuresis continues fluid input may need to be increased.
  If large volumes of gastric aspirate continue, these will need to be replaced with
  0.45% saline with KCl.
Check biochemistry, blood pH, and laboratory blood glucose 2 hours
  after the start of resuscitation, and then at least 4 hourly. Review the
  fluid composition and rate according to each set of electrolyte results.
If acidosis is not correcting, consider the following
• insufficient insulin to switch off ketones inadequate resuscitation
• sepsis hyperchloraemic acidosissalicylate or other prescription
  or recreational drugs
E. CONTINUING MANAGEMENT
• Use near-patient ketone testing to confirm that ketone levels are falling
  adequately. If blood ketones are not falling, then check infusion lines, the
  calculation and dose of insulin and consider giving more insulin.
• Consider sepsis, inadequate fluid input and other causes if sufficient insulin is being
  given.
• Insulin management once ketoacidosis resolved -
• Continue with IV fluids until the child is drinking well and able to
  tolerate food. Only change to subcutaneous insulin once blood ketone
  levels are below 1.0 mmol/l, although urinary ketones may not have
  disappeared completely.
• Discontinue the insulin infusion 60 minutes (if using soluble or long-
  acting insulin) or 10 minutes (if using Novorapid or Humalog) after
  the first subcutaneous injection to avoid rebound hyperglycaemia.
   Subcutaneous insulin should be started according to local protocols for the child
   with newly diagnosed diabetes, or the child should be started back onto their usual
   insulin regimen at an appropriate time
F. Cerebral Edema
The signs and symptoms of
cerebral oedema include
• headache & slowing of heart rate
• change in neurological status
    (restlessness,irritability, increased drowsiness,
   incontinence)
• specific neurological signs
        (eg. cranial nerve palsies)
• rising BP, decreased O2 saturation
• abnormal posturing                                    Late
More dramatic changes such as convulsions,              Sequelae
papilloedema, respiratory arrest are late signs
 associated with extremely poor prognosis
F. Cerebral Edema
• Management : If cerebral oedema is suspected
  inform senior staff immediately.
exclude hypoglycaemia as a possible cause of any behaviour change
give hypertonic (2.7%) saline (5mls/kg over 5-10 mins) or Mannitol
 0.5 – 1.0 g/kg stat (20% Mannitol over 20 minutes).
restrict IV fluids to 1/2 maintenance and replace deficit over 72 rather
 than 48 hours
the child will need to be moved to PICU- discuss with PICU consultant. Do not
  intubate and ventilate until an experienced doctor is available
once the child is stable, exclude other diagnoses by CT scan - other
 intracerebral events may occur (thrombosis, haemorrhage or infarction)
a repeated dose of Mannitol may be required after 2 hours if no response
document all events (with dates and times) very carefully in medical
 records
G. OTHER COMPLICATIONS :
• Hypoglycaemia and hypokalaemia – avoid by careful monitoring and
    adjustment of infusion rates. Consideration should be given to adding more glucose
    if BG falling quickly even if still above 4 mmol/l.
•   Systemic Infections – Antibiotics are not given as a routine unless a severe
    bacterial infection is suspected
•   Aspiration pneumonia – avoid by nasogastric tube in vomiting child with
    impaired consciousness
   – Other associations with DKA require specific management:
• Continuing abdominal pain ( may be due to liver swelling, gastritis,
  bladder retention, ileus. However, beware of appendicitis and ask for a
  surgical opinion ). A raised amylase is common in DKA.
• Other problems are pneumothorax ± pneumo-mediastinum,
  interstitial pulmonary oedema, unusual infections (eg TB, fungal
  infections), hyperosmolar hyperglycaemic non–ketotic coma,
  ketosis in type 2 diabetes.
• Discuss these with the consultant on-call.
THANK YOU

More Related Content

What's hot

Hypoglycemia in newborns
Hypoglycemia in newbornsHypoglycemia in newborns
Hypoglycemia in newborns
Amrutha Ramakrishnan Nair
 
Shock in children
Shock in childrenShock in children
Shock in children
apoorvaerukulla
 
FLUID MANAGEMENT IN NEONATES NICU
FLUID MANAGEMENT IN NEONATES NICU FLUID MANAGEMENT IN NEONATES NICU
FLUID MANAGEMENT IN NEONATES NICU
COLLEGE OF NURSING ,MEDICAL COLLGE
 
Dka management in children
Dka management in childrenDka management in children
Dka management in children
Abdulmoein AlAgha
 
Dehydraton in pediatrics
Dehydraton in pediatricsDehydraton in pediatrics
Dehydraton in pediatrics
Palanikumar Balasundaram
 
DKA in children
DKA in childrenDKA in children
DKA in children
Mostafa Shalby
 
Neonatal hypoglycemia arif
Neonatal hypoglycemia arifNeonatal hypoglycemia arif
Neonatal hypoglycemia arif
Arif Khan
 
Hyperkalemia
HyperkalemiaHyperkalemia
Hyperkalemia
samirelansary
 
neonatal Jaundice
neonatal Jaundiceneonatal Jaundice
neonatal Jaundice
Hardi Hussein
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
Azad Haleem
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in children
charithwg
 
Pediatric Parenteral Nutrition
Pediatric Parenteral Nutrition Pediatric Parenteral Nutrition
Pediatric Parenteral Nutrition
Muhammad Aizat Sofian
 
Intravenous fluids in pediatrics
Intravenous fluids in pediatricsIntravenous fluids in pediatrics
Intravenous fluids in pediatrics
Adeel Ashiq
 
Hypoglycemia in the neonate.ppt
Hypoglycemia in the neonate.pptHypoglycemia in the neonate.ppt
Hypoglycemia in the neonate.ppt
JusticeYegon1
 
Dka
DkaDka
Approach to a child with jaundice
Approach to a child with jaundice Approach to a child with jaundice
Approach to a child with jaundice
Bala Sankar
 
Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach . Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach .
Yasser Matter
 
DKA
DKADKA

What's hot (20)

Hypoglycemia in newborns
Hypoglycemia in newbornsHypoglycemia in newborns
Hypoglycemia in newborns
 
Shock in children
Shock in childrenShock in children
Shock in children
 
FLUID MANAGEMENT IN NEONATES NICU
FLUID MANAGEMENT IN NEONATES NICU FLUID MANAGEMENT IN NEONATES NICU
FLUID MANAGEMENT IN NEONATES NICU
 
Dka management in children
Dka management in childrenDka management in children
Dka management in children
 
Dehydraton in pediatrics
Dehydraton in pediatricsDehydraton in pediatrics
Dehydraton in pediatrics
 
Case of rds
Case of rdsCase of rds
Case of rds
 
DKA in children
DKA in childrenDKA in children
DKA in children
 
Neonatal hypoglycemia arif
Neonatal hypoglycemia arifNeonatal hypoglycemia arif
Neonatal hypoglycemia arif
 
Hyperkalemia
HyperkalemiaHyperkalemia
Hyperkalemia
 
neonatal Jaundice
neonatal Jaundiceneonatal Jaundice
neonatal Jaundice
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in children
 
Dka
DkaDka
Dka
 
Pediatric Parenteral Nutrition
Pediatric Parenteral Nutrition Pediatric Parenteral Nutrition
Pediatric Parenteral Nutrition
 
Intravenous fluids in pediatrics
Intravenous fluids in pediatricsIntravenous fluids in pediatrics
Intravenous fluids in pediatrics
 
Hypoglycemia in the neonate.ppt
Hypoglycemia in the neonate.pptHypoglycemia in the neonate.ppt
Hypoglycemia in the neonate.ppt
 
Dka
DkaDka
Dka
 
Approach to a child with jaundice
Approach to a child with jaundice Approach to a child with jaundice
Approach to a child with jaundice
 
Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach . Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach .
 
DKA
DKADKA
DKA
 

Viewers also liked

Dka ispad 2014
Dka ispad 2014Dka ispad 2014
Dka ispad 2014
Yash Reddy
 
Dka by dr.irappa madabhavi
Dka by dr.irappa madabhaviDka by dr.irappa madabhavi
Dka by dr.irappa madabhaviIrappa Madabhavi
 
Ueda2016 symposium -managing t2 dm with no compromise - khaled el hadidy
Ueda2016 symposium -managing t2 dm with no compromise -  khaled el hadidyUeda2016 symposium -managing t2 dm with no compromise -  khaled el hadidy
Ueda2016 symposium -managing t2 dm with no compromise - khaled el hadidy
ueda2015
 
Diabetes miellitus ALAD 2014
Diabetes miellitus ALAD 2014 Diabetes miellitus ALAD 2014
Diabetes miellitus ALAD 2014
Aleja Ayala
 
Guias ALAD
Guias ALADGuias ALAD
Nippv ,,,,,,,,,by dr irappa madabhavi
Nippv ,,,,,,,,,by dr irappa madabhaviNippv ,,,,,,,,,by dr irappa madabhavi
Nippv ,,,,,,,,,by dr irappa madabhaviIrappa Madabhavi
 
Guias alad 11_nov_2013
Guias alad 11_nov_2013Guias alad 11_nov_2013
Guias alad 11_nov_2013Julio León
 
Ueda 2016 6-diabetes in special populations - mesbah kamel
Ueda 2016 6-diabetes in special populations - mesbah kamelUeda 2016 6-diabetes in special populations - mesbah kamel
Ueda 2016 6-diabetes in special populations - mesbah kamel
ueda2015
 
Diabetic ketoacidosis nursing management
Diabetic ketoacidosis nursing managementDiabetic ketoacidosis nursing management
Diabetic ketoacidosis nursing management
yashwant ramawat
 
7349728 diabetes-nursing-care
7349728 diabetes-nursing-care7349728 diabetes-nursing-care
7349728 diabetes-nursing-careNgaire Taylor
 
Final scrub typhus-dr irappa
Final scrub typhus-dr irappaFinal scrub typhus-dr irappa
Final scrub typhus-dr irappa
Irappa Madabhavi
 
Assessment And Managment Of Critically Ill Child 1
Assessment And Managment Of Critically Ill Child 1Assessment And Managment Of Critically Ill Child 1
Assessment And Managment Of Critically Ill Child 1Dang Thanh Tuan
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in children
mohamed abdelaziz Ali
 
Danger signs in newborns
Danger signs in newbornsDanger signs in newborns
Danger signs in newbornsVarsha Shah
 
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS
Rakesh Verma
 
Dka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentDka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managment
Eyad Miskawi
 
Diabetic Ketoacidosis In Children
Diabetic Ketoacidosis In ChildrenDiabetic Ketoacidosis In Children
Diabetic Ketoacidosis In ChildrenDang Thanh Tuan
 
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)Aaromal Satheesh
 
3. ventilatory setting
3. ventilatory setting3. ventilatory setting
3. ventilatory setting
Mahmoud Elnaggar
 

Viewers also liked (20)

Dka ispad 2014
Dka ispad 2014Dka ispad 2014
Dka ispad 2014
 
Dka by dr.irappa madabhavi
Dka by dr.irappa madabhaviDka by dr.irappa madabhavi
Dka by dr.irappa madabhavi
 
Ueda2016 symposium -managing t2 dm with no compromise - khaled el hadidy
Ueda2016 symposium -managing t2 dm with no compromise -  khaled el hadidyUeda2016 symposium -managing t2 dm with no compromise -  khaled el hadidy
Ueda2016 symposium -managing t2 dm with no compromise - khaled el hadidy
 
Diabetes miellitus ALAD 2014
Diabetes miellitus ALAD 2014 Diabetes miellitus ALAD 2014
Diabetes miellitus ALAD 2014
 
Guias ALAD
Guias ALADGuias ALAD
Guias ALAD
 
Nippv ,,,,,,,,,by dr irappa madabhavi
Nippv ,,,,,,,,,by dr irappa madabhaviNippv ,,,,,,,,,by dr irappa madabhavi
Nippv ,,,,,,,,,by dr irappa madabhavi
 
Guias alad 11_nov_2013
Guias alad 11_nov_2013Guias alad 11_nov_2013
Guias alad 11_nov_2013
 
Ueda 2016 6-diabetes in special populations - mesbah kamel
Ueda 2016 6-diabetes in special populations - mesbah kamelUeda 2016 6-diabetes in special populations - mesbah kamel
Ueda 2016 6-diabetes in special populations - mesbah kamel
 
Diabetic ketoacidosis nursing management
Diabetic ketoacidosis nursing managementDiabetic ketoacidosis nursing management
Diabetic ketoacidosis nursing management
 
7349728 diabetes-nursing-care
7349728 diabetes-nursing-care7349728 diabetes-nursing-care
7349728 diabetes-nursing-care
 
Final scrub typhus-dr irappa
Final scrub typhus-dr irappaFinal scrub typhus-dr irappa
Final scrub typhus-dr irappa
 
Assessment And Managment Of Critically Ill Child 1
Assessment And Managment Of Critically Ill Child 1Assessment And Managment Of Critically Ill Child 1
Assessment And Managment Of Critically Ill Child 1
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in children
 
Danger signs in newborns
Danger signs in newbornsDanger signs in newborns
Danger signs in newborns
 
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS
 
Dka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentDka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managment
 
DKA
DKADKA
DKA
 
Diabetic Ketoacidosis In Children
Diabetic Ketoacidosis In ChildrenDiabetic Ketoacidosis In Children
Diabetic Ketoacidosis In Children
 
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)
 
3. ventilatory setting
3. ventilatory setting3. ventilatory setting
3. ventilatory setting
 

Similar to Dka picu

Dehydration
DehydrationDehydration
Dehydration
ahm732
 
Diabetic Keto acidosis DKA
Diabetic Keto acidosis DKADiabetic Keto acidosis DKA
Diabetic Keto acidosis DKAFarhan Shaikh
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
Dr. Abhinav Agarwal
 
DKA.pdf
DKA.pdfDKA.pdf
DKA.pdf
LikithaGowd1
 
Acute metabolic complications of diabetes mellitus
Acute metabolic complications of diabetes mellitusAcute metabolic complications of diabetes mellitus
Acute metabolic complications of diabetes mellitus
PushpAnjali6
 
Pediatric DKA.pptx
Pediatric DKA.pptxPediatric DKA.pptx
Pediatric DKA.pptx
sauravshishir
 
DIABETIC KETO ACIDOSIS
DIABETIC KETO ACIDOSISDIABETIC KETO ACIDOSIS
DIABETIC KETO ACIDOSIS
Aliya Emil
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosis
Aliya Emil
 
Pitfalls in DKA management.pptx
Pitfalls in DKA management.pptxPitfalls in DKA management.pptx
Pitfalls in DKA management.pptx
abubakr sowilem
 
DKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxDKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptx
radhashelly
 
Acute complications of diabetes mellitus
Acute complications of diabetes mellitusAcute complications of diabetes mellitus
Acute complications of diabetes mellitus
ikramdr01
 
DKA mgt protocol.pdf
DKA mgt protocol.pdfDKA mgt protocol.pdf
DKA mgt protocol.pdf
WoinshetMelaku
 
Acute gastroenteritis and fluid management
Acute gastroenteritis and fluid managementAcute gastroenteritis and fluid management
Acute gastroenteritis and fluid management
ProfMaila
 
Diabetes+ketoacidosis
Diabetes+ketoacidosisDiabetes+ketoacidosis
Diabetes+ketoacidosis
Abdulmoein AlAgha
 
Diabetic Ketoacidosis in Pregnancy.
Diabetic Ketoacidosis in Pregnancy.Diabetic Ketoacidosis in Pregnancy.
Diabetic Ketoacidosis in Pregnancy.
Walid Ahmed
 
MANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxMANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptx
Ankit Kumar
 
Diabetes Keto Acidosis management. .pptx
Diabetes Keto Acidosis management. .pptxDiabetes Keto Acidosis management. .pptx
Diabetes Keto Acidosis management. .pptx
KTD Priyadarshani
 
IV FLUID THERAPY IN CHILDREN.pptx
IV FLUID THERAPY IN CHILDREN.pptxIV FLUID THERAPY IN CHILDREN.pptx
IV FLUID THERAPY IN CHILDREN.pptx
HafsaHussainp
 

Similar to Dka picu (20)

Dehydration
DehydrationDehydration
Dehydration
 
Diabetic Keto acidosis DKA
Diabetic Keto acidosis DKADiabetic Keto acidosis DKA
Diabetic Keto acidosis DKA
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
DKA.pdf
DKA.pdfDKA.pdf
DKA.pdf
 
Acute metabolic complications of diabetes mellitus
Acute metabolic complications of diabetes mellitusAcute metabolic complications of diabetes mellitus
Acute metabolic complications of diabetes mellitus
 
Pediatric DKA.pptx
Pediatric DKA.pptxPediatric DKA.pptx
Pediatric DKA.pptx
 
DIABETIC KETO ACIDOSIS
DIABETIC KETO ACIDOSISDIABETIC KETO ACIDOSIS
DIABETIC KETO ACIDOSIS
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosis
 
Pitfalls in DKA management.pptx
Pitfalls in DKA management.pptxPitfalls in DKA management.pptx
Pitfalls in DKA management.pptx
 
DKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxDKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptx
 
Acute complications of diabetes mellitus
Acute complications of diabetes mellitusAcute complications of diabetes mellitus
Acute complications of diabetes mellitus
 
DKA mgt protocol.pdf
DKA mgt protocol.pdfDKA mgt protocol.pdf
DKA mgt protocol.pdf
 
Dka aguideline
Dka aguidelineDka aguideline
Dka aguideline
 
Acute gastroenteritis and fluid management
Acute gastroenteritis and fluid managementAcute gastroenteritis and fluid management
Acute gastroenteritis and fluid management
 
Diabetes+ketoacidosis
Diabetes+ketoacidosisDiabetes+ketoacidosis
Diabetes+ketoacidosis
 
pedi hypoglycemia
pedi hypoglycemiapedi hypoglycemia
pedi hypoglycemia
 
Diabetic Ketoacidosis in Pregnancy.
Diabetic Ketoacidosis in Pregnancy.Diabetic Ketoacidosis in Pregnancy.
Diabetic Ketoacidosis in Pregnancy.
 
MANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxMANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptx
 
Diabetes Keto Acidosis management. .pptx
Diabetes Keto Acidosis management. .pptxDiabetes Keto Acidosis management. .pptx
Diabetes Keto Acidosis management. .pptx
 
IV FLUID THERAPY IN CHILDREN.pptx
IV FLUID THERAPY IN CHILDREN.pptxIV FLUID THERAPY IN CHILDREN.pptx
IV FLUID THERAPY IN CHILDREN.pptx
 

Recently uploaded

Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 

Recently uploaded (20)

Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 

Dka picu

  • 1. DIABETIC KETOACIDOSIS ISPAD Clinical Practice Consensus Guidelines 2009 Compendium Diabetic ketoacidosis in children and adolescents with diabetes Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee W, Rosenbloom A, Sperling M, and Hanas R. Pediatric Diabetes 2009: 10 (Suppl. 12): 118–133.
  • 2. DIABETIC KETOACIDOSIS BSPED Recommended DKA Guidelines 2009 WORKING GROUP OF THE BRITISH SOCIETY OF PAEDIATRIC ENDOCRINOLOGY AND DIABETES Dr. Julie Edge, Consultant in Paediatric Diabetes, Oxford Children’s Hospital, • 1. Recommendation to use capillary blood ketone measurement during treatment • 2. Reduction in the degree of dehydration to be used to calculate fluids • 3. Reduction in maintenance fluid rates
  • 3. DIABETIC KETOACIDOSIS BSPED Recommended DKA Guidelines 2009 • 4. Change in the recommendations for PICU/HDU – more emphasis on safe nursing on general wards • 5. Continuation of Normal saline for the first 12 hours of rehydration • 6. Delay in insulin until fluids have been running for an hour • 7. Option to continue insulin glargine during treatment
  • 4. DIABETIC KETOACIDOSIS BSPED Recommended DKA Guidelines 2009 • 8. Reminder to stop insulin pump therapy during treatment • 9. Reminder to consider anticoagulant prophylaxis in young children, especially those with femoral lines • 10. Interpretation of blood ketone measurements if pH not improving • 11. Option to use hypertonic saline instead of mannitol for the treatment of cerebral oedema
  • 5. DIABETIC KETOACIDOSIS BSPED Recommended DKA Guidelines 2009 CAUTION These guidelines are believed to be as safe as possible in the light of current evidence. However, no guidelines can be considered entirely safe as complications may still arise. In particular the pathophysiology of cerebral oedema is still poorly understood.
  • 6. A. GENERAL : • Always consult with a more senior doctor on call as soon as you suspect DKA even if you feel confident of your management. Remember : children can die from DKA. They can die from – • Cerebral oedema • Hypokalaemia • Aspiration pneumonia
  • 7. Definition: • children and young people who have: • hyperglycaemia (BG >11 mmol/l) • pH < 7.3 • bicarbonate < 15 mmol/l and who are more than 3% dehydrated and/or vomiting and/or drowsy and/or clinically acidotic • Children who are 5% dehydrated or less and not clinically unwell (mild acidosis and not nauseated or vomiting) usually tolerate oral rehydration and subcutaneous insulin.
  • 8. B. EMERGENCY MANAGEMENT IN A & E : • 1. General Resuscitation : A, B, C. Only if shocked (poor peripheral pulses, poor capillary filling with tachycardia, and/or hypotension) give 10 ml/kg 0.9% saline as a bolus, and repeat as necessary to a maximum of 30 ml/kg. • 2. Confirm the Diagnosis : • 3. Initial Investigations : blood glucose urea and electrolytesblood gases near patient blood ketones + other investigations only if indicated e.g. PCV and full blood count, CXR, CSF, throat swab, blood culture, urinalysis, c and s etc. (DKA may rarely be ppted by sepsis, and fever is not part of DKA.)
  • 9. C. FULL CLINICAL ASSESSMENT AND OBSERVATIONS : • 1. Degree of Dehydration – Over-estimation of degree of dehydration is dangerous. Therefore do not use more than 8% dehydration in calculations • 2. Conscious Level – Institute hourly neurological observations including G C S whether or not drowsy on admission. • 3. Full Examination - looking particularly for evidence of - cerebral oedema infection ileus WEIGH THE CHILD. If this is not possible because of the clinical condition, use the most recent clinic weight as a guideline, or an estimated weight from centile charts.
  • 10. C. FULL CLINICAL ASSESSMENT AND OBSERVATIONS : 4. Consider PICU or HDU for the following, and discuss with a PICU consultant. • severe acidosis pH<7.1 with marked hyperventilation • severe dehydration with shock • depressed sensorium with risk of aspiration from vomiting • very young (under 2 years) • staffing levels on the wards are insufficient to allow adequate monitoring
  • 11. C. FULL CLINICAL ASSESSMENT AND OBSERVATIONS : 5. Observations to be carried out : recording all results and clinical signs on a flow chart. • strict fluid balance • measurement of volume of every urine sample • hourly capillary blood glucose measurements • capillary blood ketone levels every 1-2 hours (if available) • urine testing for ketones (if blood ketone testing not available) • hourly BP and basic observations • twice daily weight; can be helpful in assessing fluid balance • hourly or more frequent neurological observations initially • reporting immediately to the medical staff, even at night, symptoms of headache, or slowing of pulse rate, or any change in either conscious level or behaviour • reporting any changes in the ECG trace, especially T wave changes suggesting hyper- or hypokalaemia
  • 12. D. MANAGEMENT : 1. FLUIDS : • a) Volume of fluid – Requirement = Maintenance + Deficit – fluid already given For most children, use 5% to 8% dehydration to calculate fluids. Maintenance requirements: Weight 0 – 12.9 kg 80 ml/kg/24 hrs 13 – 19.9 kg 65 ml/kg/24 hrs 20 – 34.9 kg 55 ml/kg/24 hrs 35 – 59.9 kg 45 ml/kg/24 hrs adult (>60 kg) 35 ml/kg/24 hrs N.B. Neonatal DKA will require special consideration and larger volumes of fluid than those quoted may be required, usually 100-150 ml/kg/24 hours)
  • 14. D. MANAGEMENT : 1. FLUIDS : b) Type of fluid - • Initially use 0.9% saline with 20 mmol KCl in 500 ml, and continue this sodium concentration for at least 12 hours. • Once the blood glucose has fallen to 14 mmol/l add glucose to the fluid. After 12 hours, if the plasma sodium level is stable or increasing, change to 500ml bags of 0.45% saline/5% glucose/20 mmol KCl. • If the plasma sodium is falling, continue with Normal saline (with or without glucose depending on blood glucose levels). • Corrected sodium levels should rise as blood glucose levels fall during treatment. If they do not, then continue with Normal saline and do not change to 0.45% saline.
  • 15. D. MANAGEMENT : 1. FLUIDS : c) Oral Fluids : • In severe dehydration, impaired consciousness & acidosis do not allow fluids by mouth. A N/G tube may be necessary in the case of gastric paresis. • Oral fluids (eg fruit juice/oral rehydration solution) should only be offered after substantial clinical improvement and no vomiting • When good clinical improvement occurs before the 48hr rehydration period is completed, oral intake may proceed and the need for IV infusions reduced to take account of the oral intake.
  • 16. D. MANAGEMENT : 2. POTASSIUM : • Once the child has been resuscitated, potassium should be commenced immediately with rehydration fluid unless anuria is suspected. Therefore ensure that every 500 ml bag of fluid contains 20 mmol KCl (40 mmol per litre). • Check U & E's 2 hours after resuscitation is begun and then at least 4 hourly, and alter potassium replacements accordingly. More potassium than 40 mmol/l is occasionally required. • Use a cardiac monitor and observe frequently for T wave changes.
  • 17. D. MANAGEMENT : 3. INSULIN : DO NOT start insulin until intravenous fluids have been running for at least an hour. • Continuous low-dose intravenous infusion is the preferred method. 0.1 units/kg/hour Do not add insulin directly to the fluid bags. • Once the blood glucose level falls to 14mmol/l, change the fluid to contain 5% glucose (generally 0.9% saline with glucose and potassium). DO NOT reduce the insulin. • DO NOT stop the insulin infusion while glucose is being infused, as insulin is required to switch off ketone production. If the blood glucose falls below 4 mmol/l, give a bolus of 2 ml/kg of 10% glucose and increase the glucose concentration of the infusion. Insulin can temporarily be reduced for 1 hour.
  • 18. D. MANAGEMENT : • 4. BICARBONATE : • Bicarbonate should only be considered in children who are profoundly acidotic (pH< 6.9) and shocked with circulatory failure. Its only purpose is to improve cardiac contractility in severe shock. • Before starting bicarbonate, discuss with senior staff, and the quantity should be decided by the paediatric resuscitation team or consultant on-call. • 5. PHOSPHATE : • There is always depletion of phosphate. There is no evidence in adults or children that replacement has any clinical benefit and phosphate administration may lead to hypocalcaemia. • 6. ANTICOAGULANT PROPHYLAXIS : • There is a significant risk of femoral vein thrombosis in young and very sick children with DKA who have femoral lines inserted. Therefore consideration should be given to anticoagulating these children with 100 units/kg/day as a single daily dose of Fragmin. • Children who are significantly hyperosmolar might also require anticoagulant prophylaxis
  • 19. E. CONTINUING MANAGEMENT Urinary catheterisation should be avoided but may be useful in the child with impaired consciousness. Documentation of fluid balance is of paramount importance. If a massive diuresis continues fluid input may need to be increased. If large volumes of gastric aspirate continue, these will need to be replaced with 0.45% saline with KCl. Check biochemistry, blood pH, and laboratory blood glucose 2 hours after the start of resuscitation, and then at least 4 hourly. Review the fluid composition and rate according to each set of electrolyte results. If acidosis is not correcting, consider the following • insufficient insulin to switch off ketones inadequate resuscitation • sepsis hyperchloraemic acidosissalicylate or other prescription or recreational drugs
  • 20. E. CONTINUING MANAGEMENT • Use near-patient ketone testing to confirm that ketone levels are falling adequately. If blood ketones are not falling, then check infusion lines, the calculation and dose of insulin and consider giving more insulin. • Consider sepsis, inadequate fluid input and other causes if sufficient insulin is being given. • Insulin management once ketoacidosis resolved - • Continue with IV fluids until the child is drinking well and able to tolerate food. Only change to subcutaneous insulin once blood ketone levels are below 1.0 mmol/l, although urinary ketones may not have disappeared completely. • Discontinue the insulin infusion 60 minutes (if using soluble or long- acting insulin) or 10 minutes (if using Novorapid or Humalog) after the first subcutaneous injection to avoid rebound hyperglycaemia. Subcutaneous insulin should be started according to local protocols for the child with newly diagnosed diabetes, or the child should be started back onto their usual insulin regimen at an appropriate time
  • 21. F. Cerebral Edema The signs and symptoms of cerebral oedema include • headache & slowing of heart rate • change in neurological status (restlessness,irritability, increased drowsiness, incontinence) • specific neurological signs (eg. cranial nerve palsies) • rising BP, decreased O2 saturation • abnormal posturing Late More dramatic changes such as convulsions, Sequelae papilloedema, respiratory arrest are late signs associated with extremely poor prognosis
  • 22. F. Cerebral Edema • Management : If cerebral oedema is suspected inform senior staff immediately. exclude hypoglycaemia as a possible cause of any behaviour change give hypertonic (2.7%) saline (5mls/kg over 5-10 mins) or Mannitol 0.5 – 1.0 g/kg stat (20% Mannitol over 20 minutes). restrict IV fluids to 1/2 maintenance and replace deficit over 72 rather than 48 hours the child will need to be moved to PICU- discuss with PICU consultant. Do not intubate and ventilate until an experienced doctor is available once the child is stable, exclude other diagnoses by CT scan - other intracerebral events may occur (thrombosis, haemorrhage or infarction) a repeated dose of Mannitol may be required after 2 hours if no response document all events (with dates and times) very carefully in medical records
  • 23. G. OTHER COMPLICATIONS : • Hypoglycaemia and hypokalaemia – avoid by careful monitoring and adjustment of infusion rates. Consideration should be given to adding more glucose if BG falling quickly even if still above 4 mmol/l. • Systemic Infections – Antibiotics are not given as a routine unless a severe bacterial infection is suspected • Aspiration pneumonia – avoid by nasogastric tube in vomiting child with impaired consciousness – Other associations with DKA require specific management: • Continuing abdominal pain ( may be due to liver swelling, gastritis, bladder retention, ileus. However, beware of appendicitis and ask for a surgical opinion ). A raised amylase is common in DKA. • Other problems are pneumothorax ± pneumo-mediastinum, interstitial pulmonary oedema, unusual infections (eg TB, fungal infections), hyperosmolar hyperglycaemic non–ketotic coma, ketosis in type 2 diabetes. • Discuss these with the consultant on-call.
  • 24.